BAFNA PHARMACEUTICALS LTD. - 532989 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find attached Secretarial Compliance Report of the Company under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) ( Amendment ) Regulations 2015 issued by M/s. A.K.Jain & Associates, Company Secretaries in practice, Secretarial Auditor of the Company for the year ending 31st March 2020. BAFNA PHARMACEUTICALS LTD. - 532989 - Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Details Of Related Party Transactions
In compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, We hereby submit related party transactions as at 31st March 2020. This is for your information and record. BAFNA PHARMACEUTICALS LTD. - 532989 - Shareholding for the Period Ended June 30, 2020
Bafna Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here BAFNA PHARMACEUTICALS LTD. - 532989 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- JITENDRA KUMAR PALDesignation :- Company Secretary and Compliance Officer BAFNA PHARMACEUTICALS LTD. - 532989 - Sub.:- Discrepancies In Consolidated Financial Results
Sub.:- Discrepancies in consolidated Financial Results We acknowledge the receipt of your email dated 17th July 2020 and submit as under: Discrepancy: Declaration or Statement of Impact of Audit Qualifications not submitted Our reply: please find attached outcome of board meeting along with Statement of Impact of Audit Qualifications. BAFNA PHARMACEUTICALS LTD. - 532989 - Reg. 34 (1) Annual Report
Please find attached Annual Report for 2019_20. BAFNA PHARMACEUTICALS LTD. - 532989 - Book Closure For The Purpose Of Annual General Meeting
We would like to inform you that, further to our announcement dated 25th June 2020 the Company's register of members will be closed from 25th July 2020 to 31st July 2020 (both days inclusive) for the purpose of annual general meeting. Annual General Meeting scheduled to be held on 31st July 2020. BAFNA PHARMACEUTICALS LTD. - 532989 - Fixes Book Closure for AGM
Bafna Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 25, 2020 to July 31, 2020 (both days inclusive) for the purpose of 25th Annual General Meeting (AGM) of the Company to be held on July 31, 2020. BAFNA PHARMACEUTICALS LTD. - 532989 - Announcement under Regulation 30 (LODR)-Resignation of Director
Resignation of Mr. V.RAJAMANI BAFNA PHARMACEUTICALS LTD. - 532989 - Financial Result For The Year Ending 31St March 2020
The Board of Directors of the Company at their meeting held on today inter-alia transacted the following business.:- 1. AUDITED FINANCIAL RESULT Approval of audited financial results of the Company for the quarter and year ending 31st March 2020. M/s. R. Sathyanarayanan & Co, the Statutory Auditors of the Company have issued Audit Report with modified opinion along with Statement on impact of Modified opinion thereon. Please find enclosed 'Audited Financial Results, Audit Report, 'Statement of Assets & Liabilities' and Statement on Impact of Modified Opinion thereon for the year ended on March 31, 2020. 2. ANNUAL GENERAL MEETING The 25th Annual General Meeting of the members of the Company is scheduled to be held on Friday the 31st July 2020.